Literature DB >> 2993516

Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries.

Y Suzuki, D McMaster, M Huang, K Lederis, O P Rorstad.   

Abstract

This study reports the characterization of receptors for vasoactive intestinal peptide (VIP) on membranes prepared from bovine cerebral arteries. By use of HPLC we prepared two purified monoiodinated VIP radioligands with nearly equivalent cerebral vasorelaxant potency as native VIP, [Tyr(125I)10 )VIP and [Tyr(125I)22]VIP. The former resulted in a higher proportion of specific binding to arterial membranes than the latter and was therefore thought to be the superior radioligand for receptor characterization. The binding of [Tyr(125I)10]VIP to cerebral arterial membranes was saturable, specific, reversible, and dependent on time and temperature. Scatchard analysis suggested the presence of a high- and a low-affinity binding site with KD values of 0.2 and 11 nM and receptor concentrations of 79 and 737 fmol/mg of protein, respectively. The dose-response curves for binding to the VIP receptor by the VIP-homologous peptides PHI, PHM, and rat growth hormone-releasing factor (GRF) were very similar to their dose-response curves for relaxation of cerebral arteries. The order of potency was VIP greater than PHM greater than PHI greater than rat GRF. It is suggested that the characteristics of the vascular VIP binding sites and the close correlation between the binding and vasorelaxant properties of VIP and its related peptides argue for the vascular binding sites being functional receptors for VIP.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993516     DOI: 10.1111/j.1471-4159.1985.tb04077.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice.

Authors:  S Shen; C Spratt; W J Sheward; I Kallo; K West; C F Morrison; C W Coen; H M Marston; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

3.  Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

Authors:  U Bickel; T Yoshikawa; E M Landaw; K F Faull; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Effects of calcitonin gene-related peptide on canine cerebral artery strips and the in-vivo vertebral blood flow in dogs.

Authors:  I Ikegaki; Y Suzuki; S Satoh; T Asano; M Shibuya; K Sugita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

Review 5.  Peptides in the mammalian cardiovascular system.

Authors:  J Wharton; S Gulbenkian
Journal:  Experientia       Date:  1987-07-15

6.  Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries.

Authors:  E Hamel; L Edvinsson; E T MacKenzie
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

7.  Peptidergic modulation of the membrane potential of the Schwann cell of the squid giant nerve fibre.

Authors:  P D Evans; V Reale; J Villegas
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.